Seven Eight Capital’s Usana Health Sciences USNA Stock Holding History

Seven Eight Capital’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,499	Closed	-$437K	–	735
2019 Q2	$437K	Buy	+5,499	New	+$436K	0.02%	507
2018 Q4	–	Sell	-14,300	Closed	-$1.72M	–	719
2018 Q3	$1.72M	Buy	+14,300	New	+$1.77M	0.1%	277

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Seven Eight Capital's USNA Position: Q3 2019 in Review

Seven Eight Capital sold out of Usana Health Sciences (USNA) in Q3 2019, closing a stake of 5,499 shares — an estimated $437K sold.

Seven Eight Capital first reported a position in USNA in Q3 2018 and held it in 2 quarters. The position peaked at $1.72M in Q3 2018. 169 funds tracked by Wall St. Rank hold USNA as of Q3 2019.

Seven Eight Capital reported no remaining Usana Health Sciences position as of Q3 2019 after selling out during the quarter.
Seven Eight Capital sold 5,499 Usana Health Sciences shares in Q3 2019, an estimated $437K.
Seven Eight Capital first reported a position in Usana Health Sciences in Q3 2018 and held it in 2 quarters.
Seven Eight Capital's Usana Health Sciences position peaked at $1.72M in Q3 2018.
169 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2019.

Based on Seven Eight Capital's 13F filing for Q3 2019, filed 14 Nov 2019.